Neion Bio

Neion Bio lands $23M Series A to make proteins from chicken eggs

200 million years of evolution. Frontier genetic engineering. Tomorrow’s medicines.

We are building the biomanufacturing platform of the future, using evolution's best molecular factories.

Mission

We harness nature’s best protein factories to make medicine affordable, accessible, and resilient.

We envision a world in which producing the medicines in our hospitals is as easy and affordable as producing the food in our grocery stores.
Evolution has created wonders of engineering – autonomous, self-replicating 3D printers – capable of converting simple inputs, like grain and water, into complex outputs, like eggs and silk. What if we could re-engineer those systems to produce life-saving medicines?

Nature's best protein factories, re-engineered.

Technology

The Raptor platform

We build living bioreactors to manufacture any biomolecule at scale – powered by next-generation genetic engineering and stem cell biology.

We scale out rather than scale up

Using this evolutionarily optimized, easily replicable vessel, we manufacture recombinant therapeutics in a highly reliable manner, eliminating the risk of scale up.

Platform Technology

Raptor Line V2.5

Process

How We Scale

Our Raptor™ platform is:

We partner with

We solve critical challenges for our partners

Traditional biomanufacturing is expensive, slow to scale, highly variable from batch to batch, and vulnerable to supply chain shocks.

Neion Bio is trusted by some of the most important companies in biopharma to solve these problems, unlocking portfolio optionality and huge economic value. We develop and manufacture lower cost, higher consistency biological molecules including: monoclonal antibodies, enzymes, fusion proteins, peptides, cytokines, and other biologics.

We manufacture for therapeutic or non-therapeutic use, at any scale, with site flexibility and rapid ramp-up.

Partner with Us

Biosimilars

Access capabilities and capacity with minimal investment while preserving cost leadership.

Biotech

Develop difficult-to-express proteins, and secure long-term supply through flexible and scalable production.

Animal Health

Innovate while maintaining low COGS in a cash-pay market.

Reagents

Replace outdated infrastructure with reliable, consistent supply.

We manufacture

Careers

Come and work at the cutting edge of genome engineering, stem cell biology, and protein science. We are reinventing the infrastructure of modern medicine, democratizing access to life-saving therapeutics.